RedHill Biopharma (RDHL) Assets Average (2013 - 2025)
RedHill Biopharma (RDHL) posted quarterly Assets Average of $21.9 million for Q4 2025, up 9.12% year-over-year from $20.0 million in Q4 2024, and up 20.05% quarter-over-quarter from $18.2 million in Q2 2025.
RedHill Biopharma (RDHL) Assets Average (2013 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Assets Average for 13 consecutive years, with $21.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average rose 9.12% year-over-year to $21.9 million; the TTM figure through Dec 2025 stood at $21.9 million (up 9.12% YoY), while the FY2025 annual figure was $21.7 million, up 5.59% from the prior year.
- Assets Average climbed to $21.9 million in Q4 2025 per RDHL's latest filing, from $18.2 million in the prior quarter.
- Across five years, Assets Average topped out at $211.9 million in Q2 2021 and bottomed at $18.2 million in Q2 2025.
- Historically, Assets Average has averaged $114.7 million across 5 years, with a median of $158.0 million in 2022.
- Annual changes were most pronounced in 2021 — Assets Average surged 84.01% — and 2023, when it sank 81.62%.
- RedHill Biopharma's Assets Average stood at $183.8 million in 2021, then declined by 14.0% to $158.0 million in 2022, then tumbled by 81.62% to $29.0 million in 2023, then tumbled by 31.02% to $20.0 million in 2024, then climbed by 9.12% to $21.9 million in 2025.
- Business Quant data shows RDHL's Assets Average at $21.9 million in Q4 2025, $18.2 million in Q2 2025, and $20.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 21.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.86 Mn |
| Jun 30, 2025 | 18.21 Mn |
| Dec 31, 2024 | 20.03 Mn |
| Jun 30, 2024 | 22.54 Mn |
| Dec 31, 2023 | 29.04 Mn |
| Jun 30, 2023 | 46.94 Mn |
| Mar 31, 2023 | 108.85 Mn |
| Dec 31, 2022 | 158.03 Mn |
| Sep 30, 2022 | 162.58 Mn |
| Jun 30, 2022 | 167.51 Mn |
| Mar 31, 2022 | 174.12 Mn |
| Dec 31, 2021 | 183.76 Mn |
| Sep 30, 2021 | 195.00 Mn |
| Jun 30, 2021 | 211.90 Mn |
| Mar 31, 2021 | 200.18 Mn |
| Dec 31, 2020 | 174.61 Mn |
| Sep 30, 2020 | 167.68 Mn |
| Jun 30, 2020 | 154.93 Mn |
| Mar 31, 2020 | 108.79 Mn |
| Dec 31, 2019 | 57.17 Mn |